Expression of both Estrogen Receptor-beta 1 (ER-β1) and its co-regulator Steroid Receptor RNA Activator Protein (SRAP) are predictive for benefit from tamoxifen therapy in patients with Estrogen Receptor-alpha (ER-α)-Negative Early Breast Cancer (EBC)
Titel:
Expression of both Estrogen Receptor-beta 1 (ER-β1) and its co-regulator Steroid Receptor RNA Activator Protein (SRAP) are predictive for benefit from tamoxifen therapy in patients with Estrogen Receptor-alpha (ER-α)-Negative Early Breast Cancer (EBC)
Auteur:
Yan, Y. Li, X. Blanchard, A. Bramwell, V.H.C. Pritchard, K.I. Tu, D. Shepherd, L. Myal, Y. Penner, C. Watson, P.H. Leygue, E. Murphy, L.C.